Perspectives From FDA’s Patient Network Annual Meeting
rarediseases.org

Gov­ern­ment agen­cies, indus­try, and patient advo­ca­cy groups all agree that a patient-centered per­spec­tive is vital dur­ing the process­es of drug devel­op­ment, clin­i­cal tri­als, benefit/risk …

Perspectives From FDA’s Patient Network Annual Meeting
@myhealthshare

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s